92 related articles for article (PubMed ID: 9681607)
1. p53 protein overexpression as a predictor of the response to chemotherapy in gastric cancer.
Nakata B; Chung KH; Ogawa M; Ogawa Y; Yanagawa K; Muguruma K; Inoue T; Yamashita Y; Onoda N; Maeda K; Sawada T; Sowa M
Surg Today; 1998; 28(6):595-8. PubMed ID: 9681607
[TBL] [Abstract][Full Text] [Related]
2. [p53 and Bax protein expression as predictor of chemotherapeutic effect in gastric carcinoma].
Muguruma K; Nakata B; Hirakawa K; Yamashita Y; Onoda N; Inoue T; Matsuoka T; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():400-3. PubMed ID: 9589042
[TBL] [Abstract][Full Text] [Related]
3. p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancer.
Kikuyama S; Inada T; Shimizu K; Miyakita M; Ogata Y
Anticancer Res; 2001; 21(3C):2149-53. PubMed ID: 11501839
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of Bcl-2 and Bax protein expression for chemotherapeutic effect in gastric cancer. A pilot study.
Nakata B; Muguruma K; Hirakawa K; Chung YS; Yamashita Y; Inoue T; Matsuoka T; Onoda N; Kato Y; Sowa M
Oncology; 1998; 55(6):543-7. PubMed ID: 9778621
[TBL] [Abstract][Full Text] [Related]
5. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with irinotecan and cisplatin.
Nagashima F; Boku N; Ohtsu A; Yoshida S; Hasebe T; Ochiai A; Sakata Y; Saito H; Miyata Y; Hyodo I; Ando M
Jpn J Clin Oncol; 2005 Dec; 35(12):714-9. PubMed ID: 16303791
[TBL] [Abstract][Full Text] [Related]
6. [Association between p53 expression and chemosensitivity in advanced and recurrent gastric cancer].
Nakata B; Chung YS; Ogawa M; Maeda K; Inoue T; Yamashita Y; Sowa M
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():151-3. PubMed ID: 8678559
[TBL] [Abstract][Full Text] [Related]
7. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.
Boku N; Chin K; Hosokawa K; Ohtsu A; Tajiri H; Yoshida S; Yamao T; Kondo H; Shirao K; Shimada Y; Saito D; Hasebe T; Mukai K; Seki S; Saito H; Johnston PG
Clin Cancer Res; 1998 Jun; 4(6):1469-74. PubMed ID: 9626464
[TBL] [Abstract][Full Text] [Related]
8. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
9. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
10. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L
Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy.
Yeh KH; Shun CT; Chen CL; Lin JT; Lee WJ; Lee PH; Chen YC; Cheng AL
Hepatogastroenterology; 1999; 46(25):610-5. PubMed ID: 10228869
[TBL] [Abstract][Full Text] [Related]
12. Allelic imbalance at p53 and microsatellite instability are predictive markers for resistance to chemotherapy in gastric carcinoma.
Yashiro M; Inoue T; Nishioka N; Matsuoka T; Boland CR; Hirakawa K
Ann Surg Oncol; 2009 Oct; 16(10):2926-35. PubMed ID: 19597886
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma.
Cascinu S; Graziano F; Del Ferro E; Staccioli MP; Ligi M; Carnevali A; Muretto P; Catalano G
Cancer; 1998 Nov; 83(9):1917-22. PubMed ID: 9806649
[TBL] [Abstract][Full Text] [Related]
14. Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil.
Tahara M; Ochiai A; Fujimoto J; Boku N; Yasui W; Ohtsu A; Tahara E; Yoshida S
Oncol Rep; 2004 Jan; 11(1):9-15. PubMed ID: 14654896
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein as a predictor of the response to 5-fluorouracil and cisplatin chemotherapy in human gastrointestinal cancer cell lines evaluated with apoptosis by use of thin layer collagen gel.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Int J Oncol; 2004 Apr; 24(4):807-13. PubMed ID: 15010816
[TBL] [Abstract][Full Text] [Related]
16. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
17. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G
Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541
[TBL] [Abstract][Full Text] [Related]
18. Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer.
Kamoshida S; Suzuki M; Shimomura R; Sakurai Y; Komori Y; Uyama I; Tsutsumi Y
Br J Cancer; 2007 Jan; 96(2):277-83. PubMed ID: 17211470
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy of 5-fluorouracil and low-dose cisplatin in advanced and recurrent gastric cancer: a multicenter retrospective study in Nagasaki, Japan.
Enjoji A;
Anticancer Res; 2002; 22(2B):1135-9. PubMed ID: 12168913
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
